Revisiting CD28 Superagonist TGN1412 as Potential Therapeutic for Pediatric B Cell Leukemia: A Review

Pediatric acute lymphoblastic leukemia (ALL) represents the most common pediatric cancer diagnosis, with numbers rising gradually every year. This paper proposes a novel therapeutic agent for pediatric ALL on the basis of a failed clinical drug trial in 2006. TGN1412 was a promising therapeutic agen...

Descripción completa

Detalles Bibliográficos
Autor principal: Brown, Katelyn E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023298/
https://www.ncbi.nlm.nih.gov/pubmed/29783736
http://dx.doi.org/10.3390/diseases6020041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023298/
https://www.ncbi.nlm.nih.gov/pubmed/29783736
http://dx.doi.org/10.3390/diseases6020041

Ejemplares similares